Ya-sung W. Yang
Tri Service General Hospital SongShan Branch
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Treatment outcomes of combination versus monotherapy in Stenotrophomonas maltophilia bacteremia: a retrospective single-center analysis.
Journal: Antimicrobial agents and chemotherapy
Published: April 30, 2026
A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 11, 2026
Clinical implications of cefoperazone-sulbactam MIC values in Pseudomonas aeruginosa bloodstream infections: a multicentre study.
Journal: JAC-antimicrobial resistance
Published: October 13, 2025
Comparison of clinical and safety outcomes in patients with Stenotrophomonas maltophilia bacteremia: a trimethoprim/sulfamethoxazole versus levofloxacin monotherapy.
Journal: Infection
Published: October 07, 2025
Susceptibilities of cefiderocol, meropenem-xeruborbactam, cefepime-taniborbactam, aztreonam-avibactam, and sulbactam-durlobactam against imipenem-non-susceptible Gram-negative bacilli in Taiwan.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 06, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial.
Journal: The Lancet. Infectious diseases
Published: May 20, 2025
Comparison of clinical manifestations, antimicrobial susceptibility patterns, and carbapenem resistance determinants between Acinetobacter seifertii and Acinetobacter nosocomialis isolated in Taiwan.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: May 12, 2025
In vitro activity of cefepime-zidebactam, ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and other comparators against imipenem-non-susceptible Pseudomonas aeruginosa in Taiwan, 2022.
Journal: International journal of antimicrobial agents
Published: May 06, 2025
Clinical Characteristics of Patients with Intra-Abdominal Infection Caused by Stenotrophomonas maltophilia.
Journal: Journal of clinical medicine
Published: April 24, 2025
Acinetobacter baumannii lipooligosaccharide core region promotes CD14-dependent TLR4 endocytosis and enhances pathogenicity through interferon-β production.
Journal: PLoS pathogens
Published: April 05, 2025
Antibiotic treatment of Stenotrophomonas maltophilia bacteraemia: does trimethoprim/sulfamethoxazole dose affect clinical outcomes?
Journal: The Journal of antimicrobial chemotherapy
Published: January 20, 2025
Antimicrobial resistance among imipenem-non-susceptible Escherichia coli and Klebsiella pneumoniae isolates, with an emphasis on novel β-lactam/β-lactamase inhibitor combinations and tetracycline derivatives: The Taiwan surveillance of antimicrobial resistance program, 2020-2022.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: October 29, 2024
Last Updated: 09/26/2026